SCHEMBL4277644

SCHEMBL4277644

CCOC(=O)CCc1cc(C(=O)c2cc(OCC(C)C)cc(OCC(C)C)c2)ccc1OCC(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOS P01100 2/20 0.64
JUN P05412 2/20 0.64
ALDH1A1 P00352 5/20 0.46
HIF1A Q16665 1/20 0.46
LTB4R Q15722 1/20 0.41
TSHR P16473 3/20 0.40
HTT P42858 2/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
MYC P01106 1/20 0.37
MAX P61244 1/20 0.37
RARA P10276 1/20 0.37
RARB P10826 1/20 0.37
RARG P13631 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4276983 0.90 FOS (0.61) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4276443 0.87 FOS (0.62) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4280879 0.87 FOS (0.62) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4278071 0.86 FOS (0.84) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL2958785 0.85 FOS (0.58) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4278642 0.85 FOS (0.59) FOSJUNALDH1A1HIF1ATSHR
SCHEMBL2968551 0.84 FOS (0.55) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4277102 0.84 FOS (0.58) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL2959153 0.83 JUN (0.54) FOSJUNALDH1A1HIF1ALTB4R
SCHEMBL4279592 0.81 FOS (0.54) FOSJUNALDH1A1HIF1ALTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-05-07 US disclosed
US-7314888-B1 Compounds and medicinal use thereof TOYAMA CHEMICAL CO., LTD. (JP) 2008-01-01 US disclosed
CN-1325376-A Novel compound and medical use thereof TOYAMA CHEMICAL CO LTD (JP) 2001-12-05 CN disclosed
EP-1127869-A1 NOVEL COMPOUNDS AND MEDICINAL USE THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118169-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL USE THEREOF SP1, AP1G1, AP1M1 FOS 63/4885JUN 20/4885ALDH1A1 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.